Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Real-world treatment patterns and outcomes in patients with chronic lymphocytic leukemia previously exposed to both covalent Bruton's tyrosine kinase inhibitor and B-cell lymphoma 2 inhibitor therapy

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
COTA, Inc., New York, NY
MSD (UK) Limited, London
Merck and Co., Inc., Rahway, NJ
Merck and Co., Inc., Rahway, NJ
Merck and Co., Inc., Rahway, NJ
COTA, Inc., New York, NY
COTA, Inc., New York, NY
COTA, Inc., New York, NY
University of Rochester, Rochester, NY
Haematologica Early view Oct 8, 2026 https://doi.org/10.3324/haematol.2026.300690

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2026.300690
 
Published
2026-10-08
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Article Usage

Online Views
134
PDF Downloads
101
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online